Keyphrases
Bilateral Pneumonia
100%
Chronic Hepatitis C
100%
Clinical Course
50%
Design Case Study
50%
H1N1
50%
Hemagglutination Inhibition Antibody
100%
Humoral Antibody Response
50%
Immunocompromised Host
50%
Immunocompromised Patients
50%
Immunoglobulin
50%
Immunological Response
50%
Improved Vaccines
50%
Influenza
50%
Influenza A
50%
Influenza Vaccination
50%
Influenza Vaccine
50%
Influenza Virus
100%
Influenza-like Illness
100%
Jerusalem
50%
Protective Capacity
50%
Respiratory Infection
50%
Respiratory Tract
50%
Revaccination
50%
Secretory IgA Antibody
50%
Severe Influenza
100%
Shortness of Breath
50%
Underlying Medical Conditions
50%
Vaccination
100%
Medicine and Dentistry
Chronic Hepatitis C
100%
Disease
66%
Disease Course
33%
Dyspnea
33%
Fulminant
33%
Hemagglutination Inhibiting Antibody
100%
Humoral Antibody
33%
Immune Response
33%
Immunocompromised Patient
66%
Immunoglobulin
33%
Immunoglobulin A Antibody
33%
Influenza
100%
Influenza A
33%
Influenza A Virus (H1N1)
33%
Influenza Vaccination
33%
Influenza Vaccine
33%
Influenza Virus
66%
Respiratory Tract Infection
33%
Secretory Immunoglobulin
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Hepatitis C
100%
Disease
50%
Disease Course
25%
Dyspnea
25%
Hemagglutination Inhibiting Antibody
100%
Humoral Antibody
25%
Immunocompromised Patient
50%
Immunoglobulin
25%
Immunoglobulin A Antibody
25%
Influenza
100%
Influenza A
25%
Influenza A Virus (H1N1)
25%
Influenza Vaccine
25%
Influenza Virus
50%
Respiratory Tract
25%
Respiratory Tract Infection
25%
Secretory Immunoglobulin
25%
Vaccination Policy
100%
Immunology and Microbiology
Breathing
16%
Hemagglutination Inhibiting Antibody
100%
Hepatitis C
100%
Humoral Antibody
16%
Immune Response
16%
Immunocompromised Patient
33%
Immunoglobulin A Antibody
16%
Influenza
100%
Influenza A Virus (H1N1)
16%
Influenza Vaccine
16%
Influenza Virus
33%
Intravenous Immunoglobulin
16%
Secretory Immunoglobulin
16%
Vaccination Policy
100%
Vaccine Efficacy
33%
Veterinary Science and Veterinary Medicine
Hepatitis C
100%
Influenza Vaccine
50%
Respiratory Tract
50%